// App-Quantinova.ai

276 : Baseline Characteristics of and Early Outcomes in the First 200 Patients with RA Treated with Filgotinib in a Prospective Observational Study

Researchers

Presenter

  • James Galloway

Principal Investigators

  • Karen Bevers

  • Patrick Verschueren

  • Roberto Felice Caporali

  • Susana Romero Yuste

  • Jérôme Avouac

  • Emilia Gvozdenovic

  • Kristina Harris

  • Monia Zignani

  • Gerd Burmester

Medical Centers

  • Kings College London, London, United Kingdom

  • Hengstdal , Sint Maartenskliniek, Nijmegen, Netherlands

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University of Milan, Milan, Italy

  • Complexo Hospitalario Universiotario de Pontevedra, Vigo, Spain

  • University Paris-Sud, Paris, France

  • Galapagos, Mechelen, Belgium

  • Charite-University Medicine Berlin, Berlin, Germany

Locations

  • United States

  • United Kingdom

  • Netherlands

  • Belgium

  • Italy

  • Spain

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Complement Factor B

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • IV

Study Id's

  • NCT04871919

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved